权益分类	功能权益	普通用户	{{item.name}}会员
{{category.name}}	{{benefitItem.name}}

Total Synthesis of Alsmaphorazine A, an Alkaloid Natural Product Inhibitor of Nit

尼特生物碱天然产物抑制剂阿司马佛拉嗪 A 的全合成

基本信息

批准号：
8787119
负责人：
Allen Y. Hong
金额：
$ 4.33万
依托单位：
UNIVERSITY OF CALIFORNIA-IRVINE
依托单位国家：
美国
项目类别：
财政年份：
2013
资助国家：
美国
起止时间：
2013-01-14 至 2015-10-19
项目状态：
已结题

来源：
https://reporter.nih.gov/project-details/8787119
关键词：
Affect Aldehydes Alder plant Alkaloids Alstonia Alzheimer&apos s Disease Biological Biological Factors Cardiovascular system Cell Survival Cells Cessation of life Chemicals Collection Complex Development Disease Dose Enzymes Evaluation Family Future Generations Goals Human Immune system Indole Alkaloids Inhibitory Concentration 50 Link Lipase Malignant Neoplasms Medical Research Methods Modification Monoterpenes Nervous system structure Neurodegenerative Disorders Nitric Oxide Synthase Nitric Oxide Synthetase Inhibitor Phase Plant Sources Play Preparation Process Protein Isoforms Reaction Research Research Project Grants Respiratory System Role Route Secure Series Stroke Structure Therapeutic Ursidae Family analog chemical reaction cycloaddition enzyme activity flexibility human NOS2A protein human disease indoline inhibitor/antagonist macrophage member

项目摘要

DESCRIPTION (provided by applicant): Nitric oxide synthase plays an essential role in the proper functioning of vital processes in respiratory, cardiovascular, nervous, and immune systems, and recent advances have shown that improper enzyme function has been linked to the onset of cancer, stroke, and neurodegenerative diseases. Isoform-selective nitric oxide synthase inhibitors have been shown to modulate the activity of these enzymes and help treat numerous human diseases. Alsmaphorazine A, a monoterpene indole alkaloid isolated in small quantities from Alstonia pneumatophora, has shown promising inducible nitric oxide synthase inhibition in lipase stimulated LPS-stimulated J774.1 macrophage cells (IC50=49.2 ¿M) in a dose-dependent manner without affecting cell viability. No members of the alsmaphorazine family have been prepared by total synthesis since their discovery, so synthetic access to these compounds and unnatural analogs would enable their evaluation as nitric oxide synthase inhibitors or potential therapeutics for other diseases. This proposal describes a concise approach to the total synthesis of the unique hexacyclic core of alsmaphorazine A from simple starting materials and outlines the extension of the synthetic route to alsmaphorazine B and numerous synthetic derivatives. The approach employs an intramolecular Diels-Alder, intra- or intermolecular Heck, and (1,3)-dipolar cycloaddition to secure the caged heterocyclic framework which bears 1,2-oxazinane, isoxazolidine, and indoleneine moieties. This flexible synthetic route enables rapid evaluation of key transformations and facile modification for asymmetric synthesis or preparation of unnatural alkaloid analogs.

描述(由申请人提供)：一氧化氮合酶在呼吸、心血管、神经和免疫系统的重要过程的正常运作中起着至关重要的作用，最近的研究表明，酶功能不正常与癌症、中风和神经退行性疾病的发生有关。异构体选择性一氧化氮合酶抑制剂已被证明可以调节这些酶的活性，并帮助治疗许多人类疾病。Alsmaphorazine A是一种从高山松中分离得到的单萜吲哚生物碱，在脂酶刺激的J774.1巨噬细胞(IC50=49.2M)中显示出良好的诱导型一氧化氮合酶抑制作用，且呈剂量依赖关系，而不影响细胞活力。自发现以来，还没有通过全合成来制备阿司马布津家族的成员，因此，通过合成获得这些化合物和非天然类似物将使它们能够被评估为一氧化氮合酶抑制剂或其他疾病的潜在治疗药物。该方案描述了从简单的起始原料全合成阿司马布拉嗪A的独特的六环核心的简明方法，并概述了合成路线延伸到阿司马布拉嗪B和许多合成衍生物。该方法采用分子内Diels-Alder、分子内或分子间Heck和(1，3)-偶极环加成反应来确保含有1，2-恶嗪烷、异恶唑烷和吲哚结构的笼状杂环骨架的安全。这种灵活的合成路线可以快速评估关键转化，并对不对称合成或制备非天然生物碱类似物进行简单的修饰。